Suppr超能文献

微小RNA-296调控血管生成性内皮细胞中生长因子受体的过表达。

miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells.

作者信息

Würdinger Thomas, Tannous Bakhos A, Saydam Okay, Skog Johan, Grau Stephan, Soutschek Jürgen, Weissleder Ralph, Breakefield Xandra O, Krichevsky Anna M

机构信息

Department of Neurology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Cancer Cell. 2008 Nov 4;14(5):382-93. doi: 10.1016/j.ccr.2008.10.005.

Abstract

A key step in angiogenesis is the upregulation of growth factor receptors on endothelial cells. Here, we demonstrate that a small regulatory microRNA, miR-296, has a major role in this process. Glioma cells and angiogenic growth factors elevate the level of miR-296 in primary human brain microvascular endothelial cells in culture. The miR-296 level is also elevated in primary tumor endothelial cells isolated from human brain tumors compared to normal brain endothelial cells. Growth factor-induced miR-296 contributes significantly to angiogenesis by directly targeting the hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) mRNA, leading to decreased levels of HGS and thereby reducing HGS-mediated degradation of the growth factor receptors VEGFR2 and PDGFRbeta. Furthermore, inhibition of miR-296 with antagomirs reduces angiogenesis in tumor xenografts in vivo.

摘要

血管生成的一个关键步骤是内皮细胞上生长因子受体的上调。在此,我们证明一种小的调节性微小RNA,即miR-296,在这一过程中起主要作用。胶质瘤细胞和血管生成生长因子可提高培养的原代人脑微血管内皮细胞中miR-296的水平。与正常脑内皮细胞相比,从人脑肿瘤中分离出的原代肿瘤内皮细胞中miR-296水平也升高。生长因子诱导的miR-296通过直接靶向肝细胞生长因子调节的酪氨酸激酶底物(HGS)mRNA,对血管生成有显著贡献,导致HGS水平降低,从而减少HGS介导的生长因子受体VEGFR2和PDGFRβ的降解。此外,用抗miR-296抑制物抑制miR-296可减少体内肿瘤异种移植中的血管生成。

相似文献

1
miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells.
Cancer Cell. 2008 Nov 4;14(5):382-93. doi: 10.1016/j.ccr.2008.10.005.
3
Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway.
Blood. 2011 May 26;117(21):5762-71. doi: 10.1182/blood-2010-09-306928. Epub 2011 Apr 1.
5
Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes.
Blood. 2013 Jun 27;121(26):5192-202. doi: 10.1182/blood-2013-03-490763. Epub 2013 Apr 30.
7
Mechanism of inhibition of tumor angiogenesis by beta-hydroxyisovalerylshikonin.
Cancer Sci. 2009 Feb;100(2):269-77. doi: 10.1111/j.1349-7006.2008.01049.x.
10
Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis.
Phytomedicine. 2024 Sep;132:155830. doi: 10.1016/j.phymed.2024.155830. Epub 2024 Jun 15.

引用本文的文献

4
Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses.
Front Cell Dev Biol. 2024 Aug 28;12:1397945. doi: 10.3389/fcell.2024.1397945. eCollection 2024.
5
Role of miRNAs in neurovascular injury and repair.
J Cereb Blood Flow Metab. 2024 Oct;44(10):1693-1708. doi: 10.1177/0271678X241254772. Epub 2024 May 10.
6
Exploring the Role of microRNAs in Glioma Progression, Prognosis, and Therapeutic Strategies.
Cancers (Basel). 2023 Aug 22;15(17):4213. doi: 10.3390/cancers15174213.
7
MicroRNAs in Tumor Endothelial Cells: Regulation, Function and Therapeutic Applications.
Cells. 2023 Jun 22;12(13):1692. doi: 10.3390/cells12131692.
8
Emerging role of MicroRNA-Based theranostics in Hepatocellular Carcinoma.
Mol Biol Rep. 2023 Sep;50(9):7681-7691. doi: 10.1007/s11033-023-08586-z. Epub 2023 Jul 7.
9
Potential new therapeutic targets: Association of microRNA with atherosclerotic plaque stability.
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231185657. doi: 10.1177/03946320231185657.
10
PAX5-miR-142 feedback loop promotes breast cancer proliferation by regulating DNMT1 and ZEB1.
Mol Med. 2023 Jul 4;29(1):89. doi: 10.1186/s10020-023-00681-y.

本文引用的文献

1
miR-126 regulates angiogenic signaling and vascular integrity.
Dev Cell. 2008 Aug;15(2):272-84. doi: 10.1016/j.devcel.2008.07.008.
2
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis.
Dev Cell. 2008 Aug;15(2):261-71. doi: 10.1016/j.devcel.2008.07.002.
3
Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells.
Blood. 2008 Oct 15;112(8):3205-16. doi: 10.1182/blood-2008-03-143479. Epub 2008 Jul 24.
4
MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression.
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20350-5. doi: 10.1073/pnas.0706901104. Epub 2007 Dec 11.
5
Interfering with disease: a progress report on siRNA-based therapeutics.
Nat Rev Drug Discov. 2007 Jun;6(6):443-53. doi: 10.1038/nrd2310.
6
Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis.
Circ Res. 2007 Jul 6;101(1):59-68. doi: 10.1161/CIRCRESAHA.107.153916. Epub 2007 May 31.
7
Angiogenesis: an organizing principle for drug discovery?
Nat Rev Drug Discov. 2007 Apr;6(4):273-86. doi: 10.1038/nrd2115.
8
Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells.
Circ Res. 2007 Apr 27;100(8):1164-73. doi: 10.1161/01.RES.0000265065.26744.17. Epub 2007 Mar 22.
9
Tomographic fluorescence imaging of tumor vascular volume in mice.
Radiology. 2007 Mar;242(3):751-8. doi: 10.1148/radiol.2423052065.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验